News
FAQs about the FDA Guidance on the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products
Sep 19, 2023
Analyzing real-world data (RWD)1 to generate real-world evidence (RWE)2 is an emerging trend in the healthcare community. RWE is routinely used to evaluate a...
Read more
Leveraging Large Language Models like ChatGPT for Real-World Evidence Generation
Sep 13, 2023
Large Language Models (LLMs), including ChatGPT, have gained significant traction since late 2022, sparking debates about whether they’re mere hype or a genuine revolution. However,...
Read more
Health Economics and Outcomes Research (HEOR): A Tool to Navigate the Biopharmaceutical Marathon
Jun 13, 2023
Congratulations! The decision to embark on the journey of founding a biopharmaceutical company is a courageous step indeed. Remember, as Tony Wheeler put it, “All you’...
Read more
The Invisible Disease
May 07, 2023
“I got diagnosed in my early 20s”  “I wanted to so badly say, ‘You guys have no idea. I’m in chemotherapy. You’re a–holes....
Read more
We Now Accepting Online Credit Card Payments for Client Convenience
Apr 12, 2023
We are thrilled to announce that we now accept online credit card payments for our clients through Stripe, a safe and convenient online payment company. This...
Read more
One drug, two Prices: Understanding the Role of Pharmacy Benefit Managers in US Drug Pricing
Mar 08, 2023
Humira, a top-selling drug with $200 billion in revenue over two decades, recently lost its patent monopoly. This paved the way for biosimilars like Amjevita to...
Read more
Damn, it is the data!
Jan 23, 2023
Artificial intelligence (AI), machine learning (ML), deep learning (DL), and natural language processing (NLP) are hard-to-avoid buzzwords at professional conferences, scientific journals, technological news, social media,...
Read more